School of Medicine
Showing 101-200 of 637 Results
-
Debra Karhson
Casual - Non-Exempt, Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry and Child Development
Bio I am interested in understanding the neural mechanisms that underlie cognitive and social functioning heterogeneity in autism spectrum disorder (ASD). Impairments in social and cognitive functioning in children with ASD are intrinsically related to the changes in information processing. Moreover, social and cognitive functioning are emergent neural processes that can be manipulated by robust molecular neuromodulators. Social behaviors are specifically related to the neuropeptides, oxytocin (OT) and arginine vasopressin (AVP), while both social and cognitive functioning have been related to the endogenous cannabinoid (or endocannabinoid) system. Therefore, my postdoctoral research (funded by a T32 postdoctoral fellowship from the NIMH) investigates the role of neuromodulators (i.e., social neuropeptides and endocannabinoids) in social functioning in autistic children. My PI-lead efforts are include mass spectrometry method development and treatment-related clinical neurophysiological assessment in autistic children. Individually, my research interests are centered on leveraging a translational neuroscience skill set to interrogate information processing in ASD pathophysiology and understand its relationship with (potential dysregulation of) endocannabinoid signaling.
-
Mardi Karin, MD, FACS
Clinical Associate Professor, Surgery - General Surgery
Bio Dr. Mardi R. Karin is a board certified surgeon with over 20 years of experience and the clinical director of breast cancer care at Stanford Cancer Center South Bay. Dr. Karin specializes in the diagnosis and treatment of breast diseases and cancer. Her focus and leadership in breast cancer care includes improving coordinated care for breast cancer treatment, developing optimal survivorship plans, and extensive experience in building strong relationships with community physicians. Dr. Karin has extensive experience in a wide variety of general surgery procedures and all types of breast surgery, including breast conservation treatment. In addition, Dr. Karin is well experienced in complex breast cancer skin and nipple sparing procedures in coordination with the plastic surgeon for immediate breast reconstruction and optimal appearance with excellent outcomes.
-
Saswati Karmakar
Postdoctoral Research Fellow, Genetics
Bio Saswati Karmakar obtained her undergraduate degree in Biotechnology at Guru Gobind Singh Indraprastha University, New Delhi. She pursued her Ph.D. in Biochemistry and Molecular Biology at the University of Nebraska Medical Center, Omaha, working on the molecular characterization of pancreatic cancer stem cells and their contribution to cancer initiation and progression. Then, she moved to Stanford University with the National Cancer Institute's F99/K00 award for a postdoctoral position in Monte Winslow's lab. Saswati's current research explores the role of tumor suppressor genes in pancreatic cancer pathogenesis.
-
Karthikeshwar Kasirajan (Kasi)
Clinical Professor, Surgery - Vascular Surgery
Bio Dr. Kasirajan is a board-certified, fellowship-trained vascular surgeon. Also known as Dr. Kasi, he is a clinical professor of vascular surgery at Stanford University School of Medicine.
Dr. Kasirajan preserves limbs, facilitates access to dialysis, and helps his patients manage conditions such as aneurysms, varicose veins, thoracic outlet syndrome, and deep vein thrombosis. Many of his limb preservation patients smoke, have diabetes, or are experiencing renal failure. Dr. Kasirajan’s experience also centers around the treatment of aneurysms and prevention of strokes.
In all cases, his goal is to provide either noninvasive or minimally invasive management whenever possible. He performs open surgery only when it is the best option. Dr. Kasirajan treats many patients with stents and stent grafts, which can shorten hospital stays and recovery times.
Dr. Kasirajan (Kasi) receives referrals of patients from primary care physicians, nephrologists, podiatrists, cardiologists, woundcare specialists, diabetologists, neurologists, and other specialists. He welcomes referrals as early as possible, ideally before patients become symptomatic. A strong proponent of doing early screening for peripheral artery disease, Dr. Kasirajan advocates for the use of the ankle-brachial index (ABI) in routine physical examinations. When providers detect an imbalance between leg and arm blood pressure, Dr. Kasirajan can help create customized strategies to address the cause before the problem worsens.
In addition to offering excellent vascular care to the community, Dr. Kasirajan joined Stanford to continue pursuing his research interests. He has conducted research into advances in minimally invasive procedures for stroke prevention and for aneurysm management. His research has also focused on how to improve surgery outcomes to help patients suffering from peripheral vascular disease. Dr. Kasirajan has been the investigator in over 40 multicenter studies involving new stent graphs, thrombectomy catheters, and other advances in endovascular technology.
Dr. Kasirajan has made more than 100 presentations worldwide on minimally invasive vascular surgery techniques and preventive care in the vascular patient. He has spoken at multiple conferences including the Society for Vascular Surgery, Peripheral Vascular Society, and the South Asian American Vascular Society. He has earned numerous honors for his academic achievements, including the prestigious Alpha Omega Alpha award for medical student and resident education.
As the author of more than 120 journal articles, Dr. Kasirajan’s work has appeared in the Journal of Vascular Surgery, Endovascular Today, Pharmacogenomics Journal, Catheter Cardiovascular Intervention, and many other publications. He also has authored 20 book chapters in textbooks including Medical Management of the Surgical Patient 5th Edition, Advances in Phlebology and Venus Surgery Volume 1, Current Therapy in Vascular Surgery, Mastery of Surgery, and many more.
Dr. Kasirajan has served on the editorial boards of the Journal of Endovascular Therapy, Annals of Vascular Surgery, International Journal of Angiology, and other publications. -
Laura B. Kasper, PhD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Bio I am psychologist and have been practicing psychotherapy for over 18 years. I have experience working with a diverse group of clients with respect to presenting concerns, gender, sexual orientation, and race/ethnicity.
Regardless of their background, the majority of my clients are highly intelligent and accomplished people who are interested in taking their personal and professional relationships to the next level, starting with themselves. My therapeutic approach blends my first-hand experience of the high-performing professional workplace with buddhist psychology and tools to offer support that is unrelentingly compassionate, direct, and powerful.
I have particular research and clinical expertise in authenticity with one's self and in relationships, interpersonal communication, and issues of sexual orientation, gender, and sexuality. My services include individual, couples, and group psychotherapy. I also do video counseling sessions with individuals and couples in CA, DC and VA, the places where I am licensed.
I earned my master’s and doctoral degrees from the University of Maryland’s Counseling Psychology program. I completed my internship and post-doctoral training, and was a Staff Psychologist at the The George Washington University Counseling Center for several years before starting my private practice. I am currently in the Interpersonal Dynamics Facilitator Training Program at Stanford University in the Graduate School of Business to become a small group facilitator for their popular elective, Interpersonal Dynamics.
I have been practicing Vipassana meditation for over fifteen years. I’ve spent eighty-five days on silent meditation retreats in that time, and have a mindfulness orientation to my work.
I am a member of the American Group Psychotherapy Association and the Northern California Group Psychotherapy Society, and the Northern California Society for Psychoanalytic Psychology. I am licensed and insured in California (PSY28532), Washington D.C. (PSY1000362) and Virginia (PSY0810004715). -
Michele Kastelein
Clinical Assistant Professor, Medicine - Vaden Health Center
Current Research and Scholarly Interests At Stanford University School of Medicine, one of our major goals is to translate research insights into practical advances that enhance and prolong life. We foster a two-way transfer of knowledge between research laboratories and patient-care settings. Our faculty, staff, postdoctoral scholars and students engage in interdisciplinary efforts to turn this knowledge into therapies that treat or prevent disease.
-
Max Kasun
Roberts Ethics Lab, Psychiatry and Behavioral Sciences
Bio Max Kasun works in the Roberts Ethics Lab at Stanford.
-
Tamiko Katsumoto
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Bio Tamiko Katsumoto, MD, is a Clinical Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in the immunology lab of Dr. Arthur Weiss. Dr. Katsumoto’s research interests include the discovery of novel biomarkers to predict the development of immune-related adverse events in cancer patients on immune checkpoint inhibitor therapies, and optimizing the management of such complications. She serves as the director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of patients on checkpoint inhibitors. She is fascinated by the relationship between cancer and autoimmune diseases such as scleroderma and dermatomyositis, and the paraneoplastic manifestations of various cancers. She has spent time at Genentech, where she led several clinical trials in immunology.
-
Maya Katz, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Bio Dr. Katz is a board-certified neurologist who specializes in the treatment of Parkinson’s disease and other movement disorders. She is also a clinical associate professor of neurology at Stanford University School of Medicine.
In her clinical practice, she develops a comprehensive, compassionate treatment plan for every patient in her care. She excels at deep brain stimulation, neuromodulation, and other advanced treatment approaches. She also works closely with each patient’s caregivers and family members to help ensure optimal well-being and quality of life for all involved in the management of Parkinson’s disease, Huntington’s disease, Lewy body dementia, progressive supranuclear palsy, and other conditions.
Her research activities include serving as a co-investigator of the Parkinson’s Progression Markers Initiative funded by the Michael J. Fox Foundation. She is a site principal investigator for a National Institutes of Health-funded study of the application of palliative care to Parkinson’s disease. Previously, she was a co-investigator for studies of remote access to care for Parkinson’s disease and patient-centered outcomes in Parkinson’s disease, both funded by the National Parkinson Foundation.
Dr. Katz has earned many honors, including the ”Advancing Parkinson’s Therapies” conference award from the Parkinson’s Foundation and the “Fostering New Directions in Research” award from the Movement Disorders Society. She won scholarships from Weill Cornell Medical College, the Joseph Collins Foundation, and Anna E. Ray Robinson Education Fund.
She has presented her research findings at global meetings such as the International Parkinson and Movement Disorders Society and the International Palliative Care Society. She also has made presentations at national meetings of the American Academy of Neurology as well as regional conferences.
She has authored numerous articles on the topics of outpatient palliative care for Parkinson’s disease, caregiver burden in Parkinson’s disease, virtual visits for Parkinson’s disease, and diagnosis of cervical dystonia. Her work has appeared in journals including Neurology, Annals of Palliative Medicine, Contemporary Clinical Trials, Movement Disorders Clinical Practice, and Neurotherapeutics.
In addition, she is a reviewer for JAMA Neurology, the Journal of Neurological Sciences, Journal of Parkinson’s Disease, the brain imaging and stimulation section of Frontiers in Human Neuroscience, and Parkinsonism and Related
Disorders.
Dr. Katz is a member of the American Academy of Neurology, International Parkinson and Movement Disorders Society, Parkinson’s Foundation, Parkinson’s Study Group, American Academy of Hospice and Palliative Medicine, and American Telemedicine Association. She also is an invited speaker at community support groups for people with Parkinson’s disease. -
Laurence Katznelson, MD
Professor of Neurosurgery and of Medicine (Endocrinology) at the Stanford University Medical Center, Lucile Salter Packard Children's Hospital and at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests Dr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
Maninder P. Kaur, MD
Clinical Instructor, Neurology & Neurological Sciences
Bio Dr. Kaur is a board-certified, fellowship-trained neurologist subspecializing in onco-neurology and vascular neurology. She is a clinical instructor in the Department of Neurology at Stanford University School of Medicine.
Dr. Kaur’s clinical interests include vascular neurology; neuro-oncology, with emphasis in primary and metastatic brain and spinal tumor; and complications of brain cancer and chemotherapy, including impacts on the vascular system. She has earned transcranial Doppler certification and is a registered vascular technologist. She is passionate about caring for underserved populations.
As a clinical researcher, Dr. Kaur has explored innovations in neuro-oncological treatment modalities, including the combined use of multiple novel medication therapies with radiation for glioblastoma. She has also studied advances in endovascular treatment of pseudotumor cerebri.
Dr. Kaur has written about alveolar hemorrhage in conjunction with lupus for the peer-reviewed journal Case Reports in Medicine. In addition, she co-authored the book chapter on neuro-oncology in Synopsis of Neurological and Psychiatric Complications of Systemic Disease. She also authored the book chapter “Brain Edema and Corticosteroid Toxicity” in Brain Tumors: A Pocket Guide.
Dr. Kaur has delivered presentations on topics such as the role of transcranial Doppler in predicting CAR-T cell-induced encephalopathy. She has also given a series of presentations on treatment methods for vasospasms while at the JFK-Hackensack Medical Center in Seton Hall University. Among her honors and awards, Dr. Kaur has won recognition for a poster presentation on stroke management at the Neuroimaging Conference.
Dr. Kaur is a member of the American Academy of Neurology, American Heart Association/American Stroke Association, Society for Neuro-Oncology, and American Society of Neuroimaging. -
Abhinav Kaushik
Postdoctoral Research Fellow, Sean N Parker Center for Allergy & Asthma Research
Bio Abhinav Kaushik, PhD
Post-Doctoral Scholar
My current position at Stanford involves single cell Mass cytometry (CyTOF), gene expression and DNA methylation data analysis, as well as integrative analysis of single-cell datasets. I am working with a team to standardize the CyTOF data analysis pipeline using different statistical modeling approaches (linear or non-linear, Bayesian inference).
I have a strong experience in analyzing RNAseq, DNAseq and ChIP-seq data analysis. I am a programmer who loves to code with R, C# and perl. My keen interest includes application development for analyzing scientific data using different statistical approaches. However, my work is not restricted to one particular domain and sometimes includes in silico data analysis and algorithm development for solving both genomics and structural biology problems.
I have joined the Nadeau Laboratory at the Sean N. Parker Center for Allergy and Asthma Research at Stanford in July 2018. I received my PhD in Bioinformatics from the International Centre for Genetic Engineering and Biotechnology, India in 2017. Before joining the Nadeau Laboratory, I worked as a Visiting Researcher in the Pathogen Genomics laboratory at Kings Abdullah University of Science and Technology (KAUST), Saudi Arabia. -
Makoto Kawai
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine
Bio I am a physician scientist in the field of sleep medicine in aging and brain function. Using combined polysomnogram and novel neuroimaging technology, I aim to identify potential sleep biomarkers to investigate the mechanism of progression from normal aging to Mild Cognitive Impairment (MCI) or dementia. I also investigate the impact of sleep on cognitive/affective function or behavior abnormality in various neurodevelopmental and neurodegenerative disorders.
-
Masataka Kawana
Instructor, Medicine - Cardiovascular Medicine
Bio Dr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018 as an Instructor in the Division of Cardiovascular Medicine. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He sees advanced heart failure patients in the clinic and attends CCU/heart failure service, and post-heart transplant and MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy in inherited cardiomyopathy and also conducting a device study in heart failure.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor in Pediatrics, and Professor of Genetics
Current Research and Scholarly Interests Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Debra Lee Kaysen
Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences) at the Stanford University Medical Center
Current Research and Scholarly Interests Much of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.
Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment. -
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly Interests Dr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
-
Corey Keller, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests The goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders. -
Eric J. Keller
Postdoctoral Medical Fellow, Radiology
Current Research and Scholarly Interests I am primarily working on developing applied ethics, a practical, ground-up approach to helping clinicians navigate sticky/challenging situations in healthcare. I also study professional cultures in healthcare, i.e., clinician-administration relationships or how does an internist think differently than a general surgeon and how does this affect their behaviors.
-
Jennifer Keller
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests interpersonal violence and abuse prevention; empowerment of women; cognitive and affective information processing in depression; clinical, biological, and neuropsychological aspects of depression; South Asian mental health
-
Richard Kempson
Professor of Pathology, Emeritus
Current Research and Scholarly Interests Clinicopathologic studies in endometrial carcinoma, ovarian neoplasms, and soft tissue tumors.
-
Joan Kendig
Professor of Biology in the Department of Anesthesia, Emeritus
Current Research and Scholarly Interests My laboratory tries to find out how pharmacologic agents used in the practice of anesthesia (general anesthetic and analgesic agents) lead to therapeutically desireable endpoints including unconsciousness, immobility and absence of pain. The old idea that general anesthetics are uniformly non-specific "membrane stabilizers" is giving way to a new realization that these agents exert specific actions on particular ion channels and intracellular signalling systems.